Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Otani, K.
Mihara, K.
Kondo, T.
Okada, M.
Kaneko, S.
and
Fukushima, Y.
1992.
Treatment of neuroleptic malignant syndrome with levodopa.
Human Psychopharmacology: Clinical and Experimental,
Vol. 7,
Issue. 3,
p.
217.
Okada, Fumihiko
Sasa, Hiroshi
Otani, Koichi
Kaneko, Sunao
Fukushima, Yutaka
and
Nomura, Kazuo
1993.
Letters.
Human Psychopharmacology: Clinical and Experimental,
Vol. 8,
Issue. 5,
p.
371.
Tanaka, Osamu
Otani, Koichi
Kondo, Tsuyoshi
Kaneko, Sunao
and
Fukushima, Yutaka
1993.
Paralytic ileus as a prodromal symptom of the neuroleptic malignant syndrome.
Human Psychopharmacology: Clinical and Experimental,
Vol. 8,
Issue. 5,
p.
367.
Ueno, Shu-ichi
Otani, Koichi
Kaneko, Sunao
Koshiro, Kazuko
Kondoh, Keiji
Kotani, Yasunori
and
Sano, Akira
1996.
Cytochrome P-450 2D6 gene polymorphism is not associated with neuroleptic malignant syndrome.
Biological Psychiatry,
Vol. 40,
Issue. 1,
p.
72.
Otani, Koichi
and
Aoshima, Toshiaki
2000.
Pharmacogenetics of Classical and New Antipsychotic Drugs.
Therapeutic Drug Monitoring,
Vol. 22,
Issue. 1,
p.
118.
Mihara, Kazuo
Kondo, Tsuyoshi
Yasui-Furukori, Norio
Ono, Shingo
Kaneko, Sunao
and
Otani, Koichi
2002.
Dopamine D2 receptor gene polymorphisms and clinical response to selective dopamine receptor antagonists.
International Congress Series,
Vol. 1244,
Issue. ,
p.
77.
Kawanishi, Chiaki
2003.
Genetic Predisposition to Neuroleptic Malignant Syndrome.
American Journal of PharmacoGenomics,
Vol. 3,
Issue. 2,
p.
89.
Chackupurakal, R.
Wild, U.
Kamm, M.
Wappler, F.
Reske, D.
and
Sakka, S.G.
2015.
Malignes neuroleptisches Syndrom.
Der Anaesthesist,
Vol. 64,
Issue. 7,
p.
527.
Langan Martin, Julie
and
Martin, Daniel J.
2016.
Life-Threatening Effects of Antipsychotic Drugs.
p.
223.
eLetters
No eLetters have been published for this article.